TIDM0QCV TIDM0Y7T 
 
 
 
   FORM 8.3 
 
   IRISH TAKEOVER PANEL 
 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, 
TAKEOVER RULES, 2013 
 
   DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 
1% OR MORE 
 
   1. KEY INFORMATION 
 
 
 
 
Name of person dealing (Note 1)                State Street Global Advisors & 
                                               Affiliates 
---------------------------------------------  ------------------------------- 
Company dealt in                               AbbVie Inc. 
---------------------------------------------  ------------------------------- 
Class of relevant security to which            US$0.01 common stock 
 the dealings being disclosed relate (Note 2) 
---------------------------------------------  ------------------------------- 
Date of dealing                                24(th) March 2020 
---------------------------------------------  ------------------------------- 
 
 
 
   2. INTERESTS AND SHORT POSITIONS 
 
   (a) Interests and short positions (following dealing) in the class of 
relevant security dealt in (Note 3) 
 
 
 
 
                                               Long             Short 
-------------------------------------  --------------------  ----------- 
                                         Number      (%)     Number  (%) 
-------------------------------------  ----------  --------  ------  --- 
(1) Relevant securities                68,013,859  4.60589% 
-------------------------------------  ----------  --------  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------  ----------  --------  ------  --- 
(3) Options and agreements to 
 purchase/sell                                N/A 
-------------------------------------  ----------  --------  ------  --- 
Total                                  68,013,859  4.60589% 
-------------------------------------  ----------  --------  ------  --- 
 
 
   (b) Interests and short positions in relevant securities of the company, 
other than the class dealt in (Note 3) 
 
 
 
 
Class of relevant security:                     Long         Short 
-------------------------------------------  -----------  ----------- 
                                             Number  (%)  Number  (%) 
-------------------------------------------  ------  ---  ------  --- 
(1) Relevant securities                       N/A 
-------------------------------------------  ------  ---  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------------  ------  ---  ------  --- 
(3) Options and agreements to purchase/sell   N/A 
-------------------------------------------  ------  ---  ------  --- 
Total                                         N/A 
-------------------------------------------  ------  ---  ------  --- 
 
 
   3. DEALINGS (Note 4) 
 
   (a) Purchases and sales 
 
 
 
 
Purchase/sale   Number of relevant securities  Price per unit (Note 5) 
--------------  -----------------------------  ----------------------- 
   Purchase                             6,300                    67.49 
--------------  -----------------------------  ----------------------- 
   Purchase                             9,400                    67.49 
--------------  -----------------------------  ----------------------- 
   Purchase                            58,000                    69.28 
--------------  -----------------------------  ----------------------- 
   Purchase                            17,400                    67.49 
--------------  -----------------------------  ----------------------- 
   Purchase                               400                   184.89 
--------------  -----------------------------  ----------------------- 
   Purchase                             6,800                    68.69 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,000                    69.28 
--------------  -----------------------------  ----------------------- 
   Purchase                             3,900                    68.94 
--------------  -----------------------------  ----------------------- 
   Purchase                               293                    67.49 
--------------  -----------------------------  ----------------------- 
   Purchase                           184,912                    67.49 
--------------  -----------------------------  ----------------------- 
   Purchase                            71,496                    67.49 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,856                    67.49 
--------------  -----------------------------  ----------------------- 
   Purchase                               480                    67.49 
--------------  -----------------------------  ----------------------- 
   Purchase                             3,536                    67.49 
--------------  -----------------------------  ----------------------- 
   Purchase                             2,907                    67.49 
--------------  -----------------------------  ----------------------- 
   Purchase                               534                    67.49 
--------------  -----------------------------  ----------------------- 
   Purchase                               564                    67.49 
--------------  -----------------------------  ----------------------- 
   Purchase                               500                    67.49 
--------------  -----------------------------  ----------------------- 
     Sale                               1,000                    67.49 
--------------  -----------------------------  ----------------------- 
     Sale                               5,079                    67.49 
--------------  -----------------------------  ----------------------- 
     Sale                                 500                    70.22 
--------------  -----------------------------  ----------------------- 
     Sale                                 400                   184.89 
--------------  -----------------------------  ----------------------- 
     Sale                                 200                    70.22 
--------------  -----------------------------  ----------------------- 
     Sale                              88,011                    67.49 
--------------  -----------------------------  ----------------------- 
     Sale                              15,888                    67.49 
--------------  -----------------------------  ----------------------- 
     Sale                               2,500                    67.49 
--------------  -----------------------------  ----------------------- 
     Sale                              10,362                    67.49 
--------------  -----------------------------  ----------------------- 
     Sale                              10,024                    67.49 
--------------  -----------------------------  ----------------------- 
     Sale                                 720                    67.49 
--------------  -----------------------------  ----------------------- 
     Sale                                 500                    69.07 
--------------  -----------------------------  ----------------------- 
     Sale                                  91                    67.49 
--------------  -----------------------------  ----------------------- 
     Sale                               6,000                    71.08 
--------------  -----------------------------  ----------------------- 
     Sale                               3,500                    68.57 
--------------  -----------------------------  ----------------------- 
     Sale                                 969                    67.49 
--------------  -----------------------------  ----------------------- 
 
 
   (b) Derivatives transactions (other than options transactions) 
 
 
 
 
Product name,  Nature of transaction  Number of relevant securities  Price per unit 
 e.g. CFD       (Note 6)               (Note 7)                       (Note 5) 
-------------  ---------------------  -----------------------------  -------------- 
N/A 
-------------  ---------------------  -----------------------------  -------------- 
 
 
   (c) Options transactions in respect of existing relevant securities 
 
   (i) Writing, selling, purchasing or varying 
 
 
 
 
Product name,      Writing, selling,  Number of             Exercise  Type, e.g.      Expiry  Option money 
 e.g. call option   purchasing         securities to which   price     American,       date    paid/received 
                    varying etc.       the option relates              European etc.           per unit (Note 5) 
                                       (Note 7) 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
N/A 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
 
 
   (ii) Exercising 
 
 
 
 
Product name,      Number of securities  Exercise price per 
 e.g. call option                           unit (Note 5) 
-----------------  --------------------  ------------------ 
N/A 
-----------------  --------------------  ------------------ 
 
 
   (d) Other dealings (including transactions in respect of new securities) 
(Note 4) 
 
 
 
 
Nature of transaction  Details       Price per unit 
 (Note 8)                        (if applicable) (Note 5) 
---------------------  -------  ------------------------- 
N/A 
---------------------  -------  ------------------------- 
 
 
   4. OTHER INFORMATION 
 
   Agreements, arrangements or understandings relating to options or 
derivatives 
 
 
 
 
Full details of any agreement, arrangement or understanding 
 between the person disclosing and any other person 
 relating to the voting rights of any relevant securities 
 under any option referred to on this form or relating 
 to the voting rights or future acquisition or disposal 
 of any relevant securities to which any derivative 
 referred to on this form is referenced. If none, this 
 should be stated. 
----------------------------------------------------------- 
N/A 
----------------------------------------------------------- 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                     NO 
-------------------------------------------------------  ----------------- 
Date of disclosure                                       25(th) March 2020 
-------------------------------------------------------  ----------------- 
Contact name                                               Lionel Colaco 
-------------------------------------------------------  ----------------- 
Telephone number                                              020 33956098 
-------------------------------------------------------  ----------------- 
If a connected EFM, name of offeree/offeror with which   N/A 
 connected 
-------------------------------------------------------  ----------------- 
If a connected EFM, state nature of connection (Note     N/A 
 10) 
-------------------------------------------------------  ----------------- 
 
 
 
 
 
 

(END) Dow Jones Newswires

March 25, 2020 11:00 ET (15:00 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From May 2020 to Jun 2020 Click Here for more Allergan Charts.
Allergan (NYSE:AGN)
Historical Stock Chart
From Jun 2019 to Jun 2020 Click Here for more Allergan Charts.